Taking the above results and ours together, we can conclude that we have preliminarily determined the role of IRX2, SPINK13, and CAPN8 in LUAD, making them more likely to be used as therapeutic targets for tumor therapy. The gene discussed is IRX2; the disease is neoplasm.